Literature DB >> 19665041

Ionizing radiation modulates the surface expression of human leukocyte antigen-G in a human melanoma cell line.

Severino Michelin1, Cristina E Gallegos, Diana Dubner, Benoit Favier, Edgardo D Carosella.   

Abstract

Human leukocyte antigen G (HLA-G) is a nonclassical HLA class I molecule involved in fetus protection from the maternal immune system, transplant tolerance, and viral and tumoral immune escape. Tumor-specific HLA-G expression has been described for a wide variety of malignancies, including melanomas. The aim of this study was to evaluate whether ionizing radiation (IR) could modulate the surface expression of HLA-G1 in a human melanoma cell line that expresses endogenously membrane-bound HLA-G1. For this purpose, cells were exposed to increasing doses of gamma-irradiation (0-20 Gy) and HLA-G1 levels at the plasma membrane were analyzed at different times postirradiation by flow cytometry. HLA-G total expression and the presence of the soluble form of HLA-G1 (sHLA-G1) in the culture medium of irradiated cells were also evaluated. IR was capable of downregulating cell surface and total HLA-G levels, with a concomitant increase of sHLA-G1 in the medium. These results could indicate that gamma-irradiation decreases HLA-G1 surface levels by enhancing the proteolytic cleavage of this molecule.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665041     DOI: 10.1016/j.humimm.2009.07.030

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

Review 1.  Cancer treatment and the KIR-HLA system: an overview.

Authors:  Patrizia Leone; Valli De Re; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  Clin Exp Med       Date:  2017-02-10       Impact factor: 3.984

Review 2.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

3.  HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation.

Authors:  Tomas Hrbac; Alena Kopkova; Frantisek Siegl; Marek Vecera; Michaela Ruckova; Tomas Kazda; Radim Jancalek; Michal Hendrych; Marketa Hermanova; Vaclav Vybihal; Pavel Fadrus; Martin Smrcka; Filip Sokol; Vaclav Kubes; Radim Lipina; Ondrej Slaby; Leos Kren; Jiri Sana
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

4.  Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.

Authors:  Mathilde Allard; Romain Oger; Virginie Vignard; Jean-Michel Percier; Giulia Fregni; Aurélie Périer; Anne Caignard; Béatrice Charreau; Karine Bernardeau; Amir Khammari; Brigitte Dréno; Nadine Gervois
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

5.  HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.

Authors:  Valli De Re; Laura Caggiari; Lara Mussolin; Emanuele Stefano d'Amore; Barbara Famengo; Mariangela De Zorzi; Lia Martina; Caterina Elia; Marta Pillon; Nicola Santoro; Paola Muggeo; Salvatore Buffardi; Maurizio Bianchi; Alessandra Sala; Piero Farruggia; Luciana Vinti; Edgardo D Carosella; Roberta Burnelli; Maurizio Mascarin
Journal:  Oncotarget       Date:  2017-11-18

Review 6.  Immunomodulation of NK Cells by Ionizing Radiation.

Authors:  Jiarui Chen; Xingyu Liu; Zihang Zeng; Jiali Li; Yuan Luo; Wenjie Sun; Yan Gong; Junhong Zhang; Qiuji Wu; Conghua Xie
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

Review 7.  Immune targets in the tumor microenvironment treated by radiotherapy.

Authors:  Omer M Ozpiskin; Lu Zhang; Jian Jian Li
Journal:  Theranostics       Date:  2019-01-30       Impact factor: 11.556

Review 8.  Radiotherapy in combination with systemic therapies for brain metastases: current status and progress.

Authors:  Lei Liu; Wanqi Chen; Ruopeng Zhang; Yuekun Wang; Penghao Liu; Xin Lian; Fuquan Zhang; Yu Wang; Wenbin Ma
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

Review 9.  Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.

Authors:  Elisa C Toffoli; Abdolkarim Sheikhi; Yannick D Höppner; Pita de Kok; Mahsa Yazdanpanah-Samani; Jan Spanholtz; Henk M W Verheul; Hans J van der Vliet; Tanja D de Gruijl
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

10.  HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer

Authors:  Shirin Farjadian; Maryam Tabebordbar; Maral Mokhtari; Akbar Safaei; Mahyar Malekzadeh; Abbas Ghaderi
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.